Posted by Michael Wonder on 08 Dec 2023
FDA Approves Bio-Thera Solutions' Avzivi (bevacizumab-tnjn), a biosimilar referencing Avastin
7 December 2023 - Avzivi is the second biosimilar researched, developed, and manufactured by a Chinese pharmaceutical company to receive FDA approval in the United States.
Bio-Thera Solutions today announced that the US FDA has approved Avzivi (bevacizumab-tnjn), a biosimilar referencing Avastin.
